jak inhibitor
Showing 1 - 3 of 3
Vitiligo, JAK Inhibitor Trial in Canada, United States (Ruxolitinib 1.5% cream, NB-UVB phototherapy)
Recruiting
- Vitiligo
- JAK Inhibitor
- Ruxolitinib 1.5% cream
- NB-UVB phototherapy
-
Fountain Valley, California
- +13 more
Jul 6, 2022
Rheumatoid Arthritis, JAK Inhibitor, Musculoskeletal Ultrasound Trial in Nagasaki (upadacitinib 15mg/day)
Recruiting
- Rheumatoid Arthritis
- +3 more
- upadacitinib 15mg/day
-
Nagasaki, JapanNagasaki University Hospital
Nov 24, 2021
Rheumatoid Arthritis, JAK Inhibitor, IL-6 Inhibitor Trial in Nagasaki (filgotinib 200mg/day, subcutaneous tocilizumab
Recruiting
- Rheumatoid Arthritis
- +4 more
- filgotinib 200mg/day
- subcutaneous tocilizumab 162mg/biweekly
-
Nagasaki, JapanNagasaki University Hospital
Oct 23, 2021